HORMAD1 and ovarian carcinoma: HORMAD1 expression increased HR efficiency in HORMAD1-negative ovarian cancer cell line OVCAR5, while HORMAD1 KO decreased HR efficiency in HORMAD1-expressing ovarian cancer cell line MDAH2774 (Fig. S3B–C, E–F).